Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Staging of Non-small Cell Lung Cancer

  • Chapter
  • First Online:
Diagnostic Imaging for Thoracic Surgery

  • 926 Accesses

Abstract

The process of lung cancer staging is getting increasingly complex and requires distinct input from specialized physicians of radiology, nuclear medicine, thoracic surgery, and pathology. Also after the advent of the revised 8th edition of the TNM classification, noninvasive imaging with CT and 18F-FDG-PET, supplemented by MRI, continues to provide the initial basis for clinical staging by determining the anatomic extent of the disease and thus plays a pivotal role in the diagnosis and management of NSCLC. In cases without distant metastatic disease, pretherapeutic mediastinal staging with invasive methods (mediastinoscopy or endoscopic procedures) is mandatory to determine the most appropriate treatment strategy if imaging findings are positive or in certain scenarios that come along with a high risk of false-negative imaging results. The most important limitation inherent to the current TNM staging system is its purely anatomic character that provides insufficient information related to the many different sorts of novel targeted therapies. This translates also to imaging-derived staging of NSCLC in radiology and nuclear medicine, where—besides higher anatomic resolution and image quality—the most important remaining challenge is to gather more “functional” information and generate a more comprehensive picture of the disease by noninvasive staging methods.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization. International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Lung Cancer. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 7 May 2017.

  2. U.S. National Institutes of Health. National Cancer Institute: SEER Cancer Statistics Review, 1975–2012. http://seer.cancer.gov/csr/1975_2012/browse_csr.php?sectionSEL=15&pageSEL=sect_15_table.28.html. Accessed 7 May 2017.

  3. Denoix P. Enquête permanente dans les centres anticancéreux. Bull Inst Natl Hyg. 1946;1:70–5.

    Google Scholar 

  4. Goldstraw P, Chansky K, Crowley J, et al. International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions.; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39–51.

    Article  PubMed  Google Scholar 

  5. Birley JD, Gospodarowicz M, Wittekind C, editors. TNM classification of malignant tumours. 8th ed. Oxford: Wiley-Blackwell; 2016.

    Google Scholar 

  6. Sobin L, Gospodarowicz M, Wittekind C, editors. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009.

    Google Scholar 

  7. Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming eventh edition of the TNM classification for ung cancer. J Thorac Oncol. 2009;4(5):568–77.

    Article  PubMed  Google Scholar 

  8. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111(6):1718–23.

    Article  CAS  PubMed  Google Scholar 

  9. The Japan Lung Cancer Society. Classification of lung cancer. Tokyo: Kanehara & Co; 2000.

    Google Scholar 

  10. Rami-Porta R, Bolejack V, Crowley J, et al. IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions. The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2015;10(7):990–1003.

    Article  PubMed  Google Scholar 

  11. Eberhardt WE, Mitchell A, Crowley J, Kondo H, Kim YT, Turrisi A 3rd, Goldstraw P, Rami-Porta R, International Association for Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2015;10(11):1515–22.

    Article  PubMed  Google Scholar 

  12. Goldstraw P, Crowley J, IASCL International Lung Cancer Staging Project. The IASCL international project on lung cancer. J Thorac Oncol. 2006;1:208–86.

    Article  Google Scholar 

  13. Nair A, Klusmann MJ, Kirupa H, Jogeesvaran H, Grubnic S, Green SJ, Vlahos I. Revisions to the TNM. Staging of non–small cell lung cancer: rationale, clinicoradiologic implications, and persistent limitations. Radiographics. 2011;31:215–38.

    Article  PubMed  Google Scholar 

  14. Rami-Porta R, Asamura H, Goldstraw P. Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age—challenges and opportunities. Transl Lung Cancer Res. 2015;4(4):415–23.

    PubMed  PubMed Central  Google Scholar 

  15. Rami-Porta R, Bolejack V, Giroux DJ, Chansky K, Crowley J, Asamura H, Goldstraw P, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members and Participating Institutions. The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2014;9(11):1618–24.

    Article  CAS  PubMed  Google Scholar 

  16. MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. 2017;23:161659. https://doi.org/10.1148/radiol.2017161659.

    Article  Google Scholar 

  17. Travis WD, Asamura H, Bankier AA, et al. International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and Advisory Board Members. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2016;11(8):1204–23.

    Article  PubMed  Google Scholar 

  18. The National Lung Screening Trial Research Team. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013;368:1980–91.

    Article  CAS  PubMed Central  Google Scholar 

  19. Horeweg N, Scholten ET, de Jong PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol. 2014;15:1342–50.

    Article  PubMed  Google Scholar 

  20. De Leyn P, Dooms C, Kuzdzal J, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(5):787–98.

    Article  PubMed  Google Scholar 

  21. De Wever W, Stroobants S, Coolen J, Verschakelen JA. Integrated PET/CT in staging non-small cell lung cancer: tech-nical aspects and clinical integration. Eur Respir J. 2009;33:201–12.

    Article  PubMed  Google Scholar 

  22. Pauls S, Buck AK, Hohl K, et al. Improved non-invasive T- staging in non-small cell lung cancer by integrated 18F-FDG PET/CT. Nuklearmedizin. 2007;46:9–14.

    Article  CAS  PubMed  Google Scholar 

  23. El-Sherief AH, Lau CT, Wu CC, Drake RL, Abbott GF, Rice TW. International Association for the Study of Lung Cancer (IASLC) lymph node map: radiologic review with CT illustration. Radiographics. 2014;34:1680–91.

    Article  PubMed  Google Scholar 

  24. Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, Harris LJ, Detterbeck FC. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e211S–50S.

    Article  PubMed  Google Scholar 

  25. Gould MK, Kuschner WG, Rydzak CE, et al. Test erformance of positron emission tomography and computed tomography for mediastinal staging in patients with nonsmall-cell lung cancer: a meta-analysis. Ann Intern Med. 2003;39:879–92.

    Article  Google Scholar 

  26. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s–meta-analytic comparison of PET and CT. Radiology. 1999;213:530–6.

    Article  CAS  PubMed  Google Scholar 

  27. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small-cell lung cancer: a review of the current evidence. Chest. 2003;123(1 Suppl):137S–46S.

    Article  PubMed  Google Scholar 

  28. National Institute for Health and Clinical Excellence (NICE). NICE updates guidance on the diagnosis and treatment of lung cancer. https://www.nice.org.uk/guidance/cg121/chapter/1-Guidance#diagnosis-and-staging. Accessed 22 June 2017.

  29. Boellaard R, Delgado-Bolton R, Oyen WJ, et al. European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328–54.

    Article  CAS  PubMed  Google Scholar 

  30. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500–7.

    Article  PubMed  Google Scholar 

  31. Madsen PH, Holdgaard PC, Christensen JB, et al. Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer. Eur J Nucl Med Mol Imaging. 2016;43:2084.

    Article  CAS  PubMed  Google Scholar 

  32. Fletcher JW, Kymes SM, Gould M, et al. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med. 2008;49:179–85.

    Article  PubMed  Google Scholar 

  33. Sommer G, Wiese M, Winter L, Lenz C, Klarhöfer M, Forrer F, Lardinois D, Bremerich J. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. Eur Radiol. 2012;22(12):2859–67.

    Article  PubMed  Google Scholar 

  34. Stroobants SG, D’Hoore I, Dooms C, et al. Additional value of whole-body fluorodeoxyglucose positron emission tomography in the detection of distant metastases of non-small-cell lung cancer. Clin Lung Cancer. 2003;4:242–7.

    Article  PubMed  Google Scholar 

  35. Hsia TC, Shen YY, Yen RF, Kao CH, Changlai SP. Comparing whole body 18 F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma. 2002;49(4):267–71.

    PubMed  CAS  Google Scholar 

  36. Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol. 2008;190(5):1163–8.

    Article  PubMed  Google Scholar 

  37. Eggesbø HB, Hansen G. Clinical impact of adrenal expansive lesions in bronchial carcinoma. Acta Radiol. 1996;37(3 Pt 1):343–7.

    Article  PubMed  Google Scholar 

  38. Kaltenbach TE-M, Engler P, Kratzer W, et al. Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients. Abdominal Radiology. 2016;41:25–32.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Hillers TK, Sauve MD, Guyatt GH. Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer. Thorax. 1994;49(1):14–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Hustinx R, Paulus P, Jacquet N, Jerusalem G, Bury T, Rigo P. Clinical evaluation of whole-body 18 F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. Ann Oncol. 1998;9(4):397–401.

    Article  CAS  PubMed  Google Scholar 

  41. Sommer G, Tremper J, Koenigkam-Santos M, et al. Lung nodule detection in a high-risk population: comparison of magnetic resonance imaging and low-dose computed tomography. Eur J Radiol. 2014;83(3):600–5.

    Article  PubMed  Google Scholar 

  42. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the radiologic diagnostic oncology group. Radiology. 1991;178:705–13.

    Article  CAS  PubMed  Google Scholar 

  43. Yi CA, Lee KS, Lee HY, et al. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial. Cancer. 2013;119:1784–91.

    Article  PubMed  Google Scholar 

  44. Ohno Y, Koyama H, Yoshikawa T, et al. Three-way comparison of whole-body MR, Coregistered whole-body FDG PET/MR, and integrated whole-body FDG PET/CT imaging: TNM and stage assessment capability for non-small cell lung cancer patients. Radiology. 2015;275:849–61.

    Article  PubMed  Google Scholar 

  45. Morikawa M, Demura Y, Ishizaki T, et al. The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax. J Nucl Med. 2009;50:81–7.

    Article  PubMed  Google Scholar 

  46. Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med. 2004;22:275–82.

    PubMed  Google Scholar 

  47. Shen G, Lan Y, Zhang K, Ren P, Jia Z. Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis. PLoS One. 2017;12(3):e0173104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Hochstenbag MM, Twijnstra A, Hofman P, Wouters EF, ten Velde GP. MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer. 2003;42(2):189–93.

    Article  CAS  PubMed  Google Scholar 

  49. Earnest F IV, Ryu JH, Miller GM, et al. Suspected non small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection—pilot study. Radiology. 1999;211(1):137–45.

    Article  PubMed  Google Scholar 

  50. Yokoi K, Kamiya N, Matsuguma H, et al. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest. 1999;115(3):714–9.

    Article  CAS  PubMed  Google Scholar 

  51. Van den Wyngaert T, Strobel K, Kampen WU, et al. The EANM practice guidelines for bone scintigraphy. Eur J Nucl Med Mol Imaging. 2016;43:1723–38.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Robinson LA, Wagner H Jr, Ruckdeschel JC, American College of Chest Physicians. Treatment of stage IIIA non-small cell lung cancer. Chest. 2003;123(1 Suppl):202S–20S.

    Article  PubMed  Google Scholar 

  53. Lardinois D. Pre- and intra-operative mediastinal staging in non-small-cell lung cancer. Swiss Med Wkly. 2011;141:w13168.

    PubMed  Google Scholar 

  54. Zielinski M, Szlubowski A, Kołodziej M, Orzechowski S, Laczynska E, Pankowski J, Jakubiak M, Obrochta A. Comparison of endobronchial ultrasound and/or endoesophageal ultrasound with transcervical extended mediastinal lymphadenectomy for staging and restaging of non-small-cell lung cancer. J Thorac Oncol. 2013;8(5):630–6.

    Article  PubMed  Google Scholar 

  55. Um SW, Kim HK, Jung SH, et al. Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer. J Thorac Oncol. 2015;10(2):331–7.

    Article  PubMed  Google Scholar 

  56. Zhang R, Ying K, Shi L, Zhang L, Zhou L. Combined endobronchial and endoscopic ultrasound-guided fine needle aspiration for mediastinal lymph node staging of lung cancer: a meta-analysis. Eur J Cancer. 2013;49(8):1860–7.

    Article  PubMed  Google Scholar 

  57. Van Schill PE, et al. Surgical treatment of early-stage non-small-cell lung cancer. EJC Suppl. 2013;11(2):110–22.

    Article  Google Scholar 

  58. Tournoy KG, Keller SM, Annema JT. Mediastinal staging of lung cancer: novel concepts. Lancet Oncol. 2012;13:e221–9.

    Article  PubMed  Google Scholar 

  59. Sommer G, Stieltjes B. Magnetic resonance imaging for staging of non-small-cell lung cancer—technical advances and unmet needs. J Thorac Dis. 2015;7(7):1098–102.

    PubMed  PubMed Central  Google Scholar 

  60. Ippolito D, Capraro C, Guerra L, De Ponti E, Messa C, Sironi S. Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study. Eur J Nucl Med Mol Imaging. 2013;40(2):156–65.

    Article  PubMed  Google Scholar 

  61. Sudarski S, Hagelstein C, Weis M, Schoenberg SO, Apfaltrer P. Dual-energy snap-shot perfusion CT in suspect pulmonary nodules and masses and for lung cancer staging. Eur J Radiol. 2015;84(12):2393–400.

    Article  PubMed  Google Scholar 

  62. Schwenzer NF, Schraml C, Müller M, et al. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging—pilot study. Radiology. 2012;264:551–8.

    Article  PubMed  Google Scholar 

  63. Heusch P, Buchbender C, Köhler J, et al. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT. J Nucl Med. 2014;55:373–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinic of Radiology and Nuclear Medicine, University Hospital Basel, University of Basel, Basel, Switzerland

    Gregor Sommer

  2. Clinic of Thoracic Surgery, University Hospital Basel, University of Basel, Basel, Switzerland

    Mark N. Wiese

Authors
  1. Gregor Sommer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark N. Wiese
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregor Sommer .

Editor information

Editors and Affiliations

  1. Sapienza Università di Roma, Policlinico Umberto I, Rome, Italy

    Michele Anzidei

  2. Department of Thoracic Surgery, University of Rome Sapienza, Policlinico Umberto I, Rome, Italy

    Marco Anile

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sommer, G., Wiese, M.N. (2018). Staging of Non-small Cell Lung Cancer. In: Anzidei, M., Anile, M. (eds) Diagnostic Imaging for Thoracic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-89893-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-89893-3_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-89892-6

  • Online ISBN: 978-3-319-89893-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation